Table 2.
Summary of the FNFNES pharmaceutical sampling sites of First Nations
| Year | Region | No. of First Nations* | Recreational and/or proximity to a community | Fishing sites | Drinking water sources | Proximity to wastewater | Total no. of sites |
|---|---|---|---|---|---|---|---|
| 2009 | British Columbia | 21 | 29 | 10 | 10 | 12 | 61 |
| 2010 | Manitoba | 12 | 11 | 9 | 12 | 4 | 36 |
| 2011/2012 | Ontario | 17 | 16 | 9 | 30 | 11 | 66 |
| 2013 | Alberta | 10 | 7 | 11 | 9 | 3 | 30 |
| 2014 | Atlantic Canada | 11 | 4 | 21 | 2 | 7 | 34 |
| 2015 | Saskatchewan | 14 | 12 | 18 | 2 | 10 | 42 |
| 2016 | Quebec | 10 | 10 | 8 | 9 | 6 | 33 |
| Total | 95 | 89 | 86 | 74 | 53 | 302 |
*While 95 First Nations completed the pharmaceutical component of the study, 3 First Nations in Manitoba withdrew from the larger study but continued to collaborate on the pharmaceutical study. One Ontario First Nation community withdrew from the pharmaceutical sampling component while participating in all other components of the FNFNES study in Ontario